Annual Long Term Debt
$842.40 K
+$66.80 K+8.61%
30 June 2024
Summary:
Renovaro Biosciences annual long term debt is currently $842.40 thousand, with the most recent change of +$66.80 thousand (+8.61%) on 30 June 2024. During the last 3 years, it has fallen by -$6.18 million (-88.00%). RENB annual long term debt is now -88.48% below its all-time high of $7.31 million, reached on 01 June 2020.RENB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$710.30 K
-$132.10 K-15.68%
30 September 2024
Summary:
Renovaro Biosciences quarterly long term debt is currently $710.30 thousand, with the most recent change of -$132.10 thousand (-15.68%) on 30 September 2024. Over the past year, it has increased by +$46.10 thousand (+6.94%). RENB quarterly long term debt is now -90.29% below its all-time high of $7.32 million, reached on 01 December 2020.RENB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.6% | +6.9% |
| 3 y3 years | -88.0% | -68.9% |
| 5 y5 years | +100.0% | -57.5% |
RENB Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.0% | +8.6% | -87.3% | +6.9% |
| 5 y | 5 years | -88.5% | -90.3% | +6.9% | |
| alltime | all time | -88.5% | -90.3% |
Renovaro Biosciences Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $710.30 K(-15.7%) |
| June 2024 | $842.40 K(+8.6%) | $842.40 K(-13.2%) |
| Mar 2024 | - | $970.40 K(+46.1%) |
| Dec 2023 | - | $664.20 K(-7.9%) |
| Sept 2023 | - | $720.80 K(-7.1%) |
| June 2023 | $775.60 K(-86.1%) | - |
| June 2023 | - | $775.60 K(-6.5%) |
| Mar 2023 | - | $829.20 K(-60.2%) |
| Dec 2022 | - | $2.08 M(-62.7%) |
| Sept 2022 | - | $5.59 M(+0.4%) |
| June 2022 | $5.56 M | $5.56 M(+437.3%) |
| Mar 2022 | - | $1.04 M(-54.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $2.28 M(-67.4%) |
| Sept 2021 | - | $7.02 M(-0.0%) |
| June 2021 | $7.02 M(-4.0%) | $7.02 M(-0.0%) |
| Mar 2021 | - | $7.02 M(-4.1%) |
| Dec 2020 | - | $7.32 M(+0.0%) |
| Sept 2020 | - | $7.32 M(+0.0%) |
| June 2020 | $7.31 M(>+9900.0%) | $7.31 M(+0.1%) |
| Mar 2020 | - | $7.31 M(+337.6%) |
| Dec 2019 | - | $1.67 M(-3.9%) |
| Sept 2019 | - | $1.74 M(>+9900.0%) |
| June 2019 | $0.00 | $0.00(-100.0%) |
| Dec 2016 | - | $309.60 K(-6.9%) |
| Sept 2016 | - | $332.60 K |
FAQ
- What is Renovaro Biosciences annual long term debt?
- What is the all time high annual long term debt for Renovaro Biosciences?
- What is Renovaro Biosciences annual long term debt year-on-year change?
- What is Renovaro Biosciences quarterly long term debt?
- What is the all time high quarterly long term debt for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly long term debt year-on-year change?
What is Renovaro Biosciences annual long term debt?
The current annual long term debt of RENB is $842.40 K
What is the all time high annual long term debt for Renovaro Biosciences?
Renovaro Biosciences all-time high annual long term debt is $7.31 M
What is Renovaro Biosciences annual long term debt year-on-year change?
Over the past year, RENB annual long term debt has changed by +$66.80 K (+8.61%)
What is Renovaro Biosciences quarterly long term debt?
The current quarterly long term debt of RENB is $710.30 K
What is the all time high quarterly long term debt for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly long term debt is $7.32 M
What is Renovaro Biosciences quarterly long term debt year-on-year change?
Over the past year, RENB quarterly long term debt has changed by +$46.10 K (+6.94%)